AIM ImmunoTech Statistics

Total Valuation

AIM ImmunoTech has a market cap or net worth of $6.89 million. The enterprise value is $5.59 million.

Market Cap	6.89M
Enterprise Value	5.59M

Important Dates

The next estimated earnings date is Friday, August 14, 2026, after market close.

Earnings Date	Aug 14, 2026
Ex-Dividend Date	n/a

Share Statistics

AIM ImmunoTech has 22.08 million shares outstanding. The number of shares has increased by 313.35% in one year.

Current Share Class	22.08M
Shares Outstanding	22.08M
Shares Change (YoY)	+313.35%
Shares Change (QoQ)	+50.85%
Owned by Insiders (%)	0.72%
Owned by Institutions (%)	0.80%
Float	19.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	73.32
Forward PS	n/a
PB Ratio	1.21
P/TBV Ratio	14.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	59.44
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.01, with a Debt / Equity ratio of 2.15.

Current Ratio	1.01
Quick Ratio	0.96
Debt / Equity	2.15
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-10.35

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-86.56%
Return on Invested Capital (ROIC)	-239.35%
Return on Capital Employed (ROCE)	-420.94%
Weighted Average Cost of Capital (WACC)	13.25%
Revenue Per Employee	$4,476
Profits Per Employee	-$632,190
Employee Count	21
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -96.42% in the last 52 weeks. The beta is 1.17, so AIM ImmunoTech's price volatility has been higher than the market average.

Beta (5Y)	1.17
52-Week Price Change	-96.42%
50-Day Moving Average	0.44
200-Day Moving Average	1.21
Relative Strength Index (RSI)	40.44
Average Volume (20 Days)	29,378,242

Short Selling Information

The latest short interest is 7.01 million, so 31.76% of the outstanding shares have been sold short.

Short Interest	7.01M
Short Previous Month	303,165
Short % of Shares Out	31.76%
Short % of Float	36.29%
Short Ratio (days to cover)	0.14

Income Statement

In the last 12 months, AIM ImmunoTech had revenue of $94,000 and -$13.28 million in losses. Loss per share was -$5.25.

Revenue	94,000
Gross Profit	-28,000
Operating Income	-10.27M
Pretax Income	-13.28M
Net Income	-13.28M
EBITDA	-10.08M
EBIT	-10.27M
Loss Per Share	-$5.25

Full Income Statement

Balance Sheet

The company has $5.88 million in cash and $4.57 million in debt, giving a net cash position of $1.31 million or $0.06 per share.

Cash & Cash Equivalents	5.88M
Total Debt	4.57M
Net Cash	1.31M
Net Cash Per Share	$0.06
Equity (Book Value)	2.13M
Book Value Per Share	0.26
Working Capital	69,000

Full Balance Sheet

Cash Flow

Operating Cash Flow	-11.32M
Capital Expenditures	n/a
Depreciation & Amortization	195,000
Net Borrowing	1.89M
Free Cash Flow	-11.32M
FCF Per Share	-$0.51

Full Cash Flow Statement

Margins

Gross Margin	-29.79%
Operating Margin	-10,926.60%
Pretax Margin	-14,123.40%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AIM ImmunoTech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-313.35%
Shareholder Yield	-313.35%
Earnings Yield	-192.63%
FCF Yield	-164.17%

Analyst Forecast

The average price target for AIM ImmunoTech is $5.25, which is 1,582.15% higher than the current price. The consensus rating is "Buy".

Price Target	$5.25
Price Target Difference	1,582.15%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 9, 2026. It was a forward split with a ratio of 1.001:1.

Last Split Date	Jan 9, 2026
Split Type	Forward
Split Ratio	1.001:1

Scores

AIM ImmunoTech has an Altman Z-Score of -75.8 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-75.8
Piotroski F-Score	2